Insight
Life and Health Insurance M&A
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
Equity markets started the month strongly as they initially shrugged off concerns about the coronavirus epidemic. However, by month-end, they had posted extreme losses as the virus spread worldwide and concerns grew over its impact on global growth. The FTSE 100 plunged by 9%, having lost 12% for the year so far. Equity markets in developed economies suffered heavier losses than those in emerging markets. The British government bonds index gained 1.4% in February. GBP Solvency II Risk-free rates decreased at all terms for the second month in a row. CPI inflation increased by 50 basis points to 1.8% in January. Realised volatilities surged higher for all major indices during the second half of the month, with the Euro Stoxx 50 index posting a realised volatility in excess of 31% at month-end. The S&P 500 had a realised volatility of 29.1% at month-end, almost double its historical average, while the FTSE 100 has this figure at 27.3%.
Insight
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
We’re here to help you break through complex challenges and achieve next-level success.